uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Firdapse (previously Zenas)
Authorised
Human
Details
EMA number
EMEA/H/C/001032
ATC code
N07XX05
Authorisation
23 December 2009
Revision
22
EMA page
Therapeutic indication
Symptomatic treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.
MeSH:
Lambert-Eaton Myasthenic Syndrome
Group:
Other nervous system drugs
Special characteristics
Additional monitoring
Active substances
amifampridine
Marketing Authorisation Holder
SERB SA
MAH
Timeline
Filter by authority:
EMA
Firdapse (previously Zenas) authorised
23 Dec 2009
authorised
regulatory
Firdapse (previously Zenas) | uMedical